Global Business
SAMA provides a wide range of services for pharmaceutical
products and dietary supplements as follows:
R&D
Dossier Development
In & Out Licensing
Manufacturing
- Pharmaceuticals: tablets, granules, liquids, suspensions
- Dietary supplements: chewable tablets
As one of the earliest companies to start an international license-in business, SAMA has a strong track record of new business development and partnership with overseas companies in branding and marketing to achieve # 1 brand recognition and equity. Unwavering marketing success in the field and mutual trust despite the constant changes in the market environment have been the core basis of our long-term partnership between SAMA and our partners.
SAMA is seeking potential partners in the following therapeutic areas:
Allergy, Asthma & COPD
Respiratory
Pediatrics
Dermatology
GI
Orphan diseases
SAMA is seeking out-licensing opportunities for our proprietary patented technology and products.
1) IDIA™ (Instant Dissolving and Immediate Absorption) Technology
- Quick dissolve in saliva within a few seconds
- No Residue in the mouth
- Easy swallowing
- Rapid absorption into GI through oral dissolving
- Faster onset of action
Viasin. fine granules (Sildenafil freebase) is the world’s first
granule form of Sildenafil.
- Easy to carry around in a thin paper sachet package
- Quick dissolve in your mouth without any residue
- 23% Faster to reach the Tmax than the tablet form
- Patent registration in Korea
- PCT: entry into National phase
2) SEA™ (SAMA Enhanced Absorption) Technology
- Multifactor control technology
- Enhancing solubility & bioavailability
- Reduced API dose and minimized drug size
- Minimizing drug adverse effects
Citus™ tablets (Pranlukast hydrate) is the world’s lowest dosage of Pranlukast.
- Improved patient compliance
- Increased BA more than 4 times and decreased dosage by 22% compared with the original drug
- PCT: entry into National phase